Nutra Pharma Corp. (NPHC) has shared an update.
Rik J. Deitsch has stepped down from his roles as CEO, Director, Chairman of the Board, and CFO following settlements with the SEC, which arose from allegations of federal securities law violations by Nutra Pharma Corp., Deitsch, and Sean McManus. The settlements, approved by the U.S. District Court, involve partial consent judgments that resolve liability issues but leave open questions about financial penalties and the specifics of a penny stock bar against McManus. Deitsch faces a three-year bar from officer and director roles and penny-stock offerings, while McManus is permanently enjoined from violating federal securities laws.
For detailed information about NPHC stock, go to TipRanks’ Stock Analysis page.
